Phosphorylation, ubiquitylation and characterisation of specific inhibitors of AMPK-related kinase NUAK1/ARK5
Year: 2013
Type: dissertation
Abstract: LKB1 tumor suppressor is a master upstream protein kinase responsible for activation of 14 different AMPK family members including AMPK and several less studied enzymes such as MARK, BRSK, SIK and NUAK.These enzymes are together thought to play essential roles in controlling cellular energy levels, cell polarity and proliferation.The related NUAK1 and NUAK2 are members of the AMPK family and there is increasing interest in these kinases as recent work suggests they play important roles in regulating key biological processes including Myc driven tumourigenesis, senescence, cell adhesion and neuronal polarity.Recent work from our laboratory has shown that NUAK1 phosphorylates and inhibits the myosin phosphatase complex MYPT1-PP1β following stimuli that induce cell detachment.In this work, I describe the first highly specific protein kinase inhibitors of NUAK kinases namely WZ4003 and HTH-01-015.WZ4003 inhibits both NUAK isoforms (IC50 for NUAK1 20 nM and NUAK2 100 nM), whereas HTH-01-015 inhibits only NUAK1 (IC50 100 nM).These compounds display extreme selectivity and do not significantly inhibit the activity of 139 other kinases tested including 10 AMPK family members.In all cell lines tested, WZ4003 and HTH-01-015 inhibit the phosphorylation of the NUAK substrate MYPT1 at Ser445 which can be rescued by overexpressing drug resistant NUAK1[A195T]which exhibits approximately 50 times more resistance to both the inhibitors.I also demonstrate that administration of WZ4003 and HTH-01-015 significantly inhibit cell migration, proliferation and invasion in cells to a similar extent as NUAK1 knock-out/ knockdown.My data indicate that WZ4003 and HTH-01-015 will serve as useful chemical probes to delineate the biological roles of the NUAK kinases.Furthermore, I present the evidence that NUAK1 interacts with the SCF-βTRCP complex and undergoes phosphorylation mediated degradation.NUAK1 possesses a slightly modified degron sequence that specifically binds to the SCF-βTRCP complex on PLK1 mediated phosphorylation of two serines in the degron.This interaction is lost upon mutating the serine residues on NUAK1 degron.Endogenous NUAK1 gets ubiquitylated and degraded on hyperphosphorylation and subsequently is protected from this degradation in the presence of NEDDylation inhibitor MLN-4924.The knock-out MEFs for the βTRCP1 substrate recognition motif also exhibit double the amount of NUAK1 as compared to the wild-type MEFs.Moreover, I provide evidence showing that NUAK1 is degraded in G2-M stage of the cell cycle, which is mediated by the SCF-βTRCP complex.This degradation is being triggered upon PLK1 mediated phosphorylation of the degron that can be reversed upon treatment with PLK1 inhibitor BI-2536.Thus my data suggests that NUAK1 on being phosphorylated by PLK1 binds to, and is consequently degraded by SCF-βTRCP in the G2-M stage of the cell cycle.
Author: Sourav Banerjee
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W648538967
